CAI
Clinical Asset Index
by VOS Supply Group
Drugs · acquisition-cost intelligence

Aleve Arthritis Pain Gel

Diclofenac· ingredient diclofenacAcetic acid derivatives and related substances· DICLOFENAC SODIUM .01 g/g; DICLOFENAC SODIUM 10 mg/g; DICLOFENAC SODIUM 1 g/100g; DICLOFENAC SODIUM 1 mg/100g
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per GM
$0.08776
NADAC — pharmacy acquisition cost, not a retail/cash price

Acquisition-cost history

Weekly NADAC per GM — the trend nobody else shows. 7 weeks.

2025-12-172026-05-27

Same-ingredient options by acquisition cost

Other diclofenac products, cheapest acquisition cost first. Per GM — confirm strength/form equivalence before switching.

ProductNADAC / GMvs this
Diclofenac Sodium Delayed Release$0.06665−$0.02110
Diclofenac DR$0.06665−$0.02110
Diclofenac Potassium$0.09863+$0.01090
Clofenax$0.12486+$0.03710
Diclofenac Sodium$0.36949+$0.28170
Diclofenac Sodium$0.39681+$0.30900
Diclofenac Sodium Delayed Release$0.72051+$0.63270
Diclofenac Sodium ER$0.73145+$0.64370

Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.